APA (7th ed.) Citation

Golor G, Hu K, Ruffin M, Buchelt A, Bouillaud E, Wang Y, & Maldonado M. (2012). A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers. Dove Medical Press.

Chicago Style (17th ed.) Citation

Golor G, Hu K, Ruffin M, Buchelt A, Bouillaud E, Wang Y, and Maldonado M. A First-in-man Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pasireotide (SOM230), a Multireceptor-targeted Somatostatin Analog, in Healthy Volunteers. Dove Medical Press, 2012.

MLA (9th ed.) Citation

Golor G, et al. A First-in-man Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pasireotide (SOM230), a Multireceptor-targeted Somatostatin Analog, in Healthy Volunteers. Dove Medical Press, 2012.